NATIONAL
CALIFORNIA
VENTURA
policies
- VC 705.07 Cardiac Arrest – Asystole/PEA
- VC 705.08 Cardiac Arrest – VF/VT
- VC 705.11 Crush Injury/Syndrome
- VC 705.18 Overdose
- VC 705.24 Symptomatic Bradycardia
- SB 533-09b Cardiac Arrest – VF/VT
- SB 533-09c Cardiac Arrest – Asystole/PEA
- SB 533-12 Symptomatic Bradycardia
- SB 533-26 Potential Crush Injury/Crush Syndrome
- SB 533-16 Poisoning/Overdose
- LA County Ref. No. 1210 Cardiac Arrest
- LA County Ref. No. 1212 Cardiac Dysrhythmia – Bradycardia
- LA County Ref. No. 1241 Overdose / Poisoning / Ingestion
- LA County Ref. No. 1242 Crush Injury / Syndrome
category
mechanism
- Moderates nerve and muscle performance by regulating their excitation threshold.
- In hydrofluoric acid exposures, calcium chloride provides a source of calcium which can bind fluoride ions as well as treat and prevent complications secondary to hypocalcemia; intra-arterial administration can reduce the penetration of the fluoride ion into tissues and prevent or reduce tissue destruction and pain.
indications
- Beta-blocker overdose
- Calcium channel blocker overdose
- Hyperkalemia (suspect with cardiac arrest or bradycardia in renal failure patients, or crush injuries with arrhythmias)
- Hypermagnesemia-associated cardiac arrest
- Hydrofluoric acid burns
contraindications
- Ventricular fibrillation
- Asystole
dosing
Adult
IV, IO: 1 g; may repeat as necessary
Pediatric
IV, IO: 20 mg/kg/dose (maximum dose: 1 g); may repeat as necessary
administration
Avoid rapid administration (do not exceed 100 mg/minute except in emergency situations). For patients in cardiac arrest, administer as a rapid bolus. Do not use small hand or foot veins for IV administration (severe necrosis may occur).
onset
Immediate
duration
4 hours
notes
- Cardiac arrest: Not recommended as routine treatment in cardiac arrest (includes asystole, ventricular fibrillation, pulseless ventricular tachycardia, or pulseless electrical activity)
- Extravasation: ensure proper needle position prior to and during infusion. Extravasation may result in severe necrosis. Monitor the IV site closely.
- Digoxin: Use with caution in digitalized patients; hypercalcemia may precipitate cardiac arrhythmias.
dosage form
IV solution: 1g / 10ml (10%), 10 mL vial
adverse reactions
- Cardiovascular
- Hypotension
- Arrhythmia
- Vasodilation
- Local
- Localized burning
structure